Affiliated Fund
Daily price w/o sales charge as of 07/01/2022
$15.67
$0.16
YTD Returns w/o sales charge as of 07/01/2022
-14.83%
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 05/31/2022
- Total Net Assets
- $5.90 B
- Inception Date
- 09/28/2007
- Dividend Frequency
- Quarterly
- Fund Expense Ratio
- 0.56%
- Number of Holdings
- 62
Yield
12-Month Dividend Yield 1 as of 07/01/2022
| w/o sales charge | 2.09% |
30-Day Standardized Yield 2 as of 05/31/2022
| 1.62% |
In absence of the fee waiver, yields shown would have been lower. Yields for other share classes will vary.
Fund Expense Ratio :
0.56%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 09/28/2007 |
|---|
| w/o sales charge | -15.70% | -6.92% | 4.93% | 6.12% | 10.01% | 5.31% |
| Lipper Category Avg. Equity Income Funds | - | - | - | - | - | - |
| Russell 1000® Value Index | -12.86% | -6.82% | 6.87% | 7.17% | 10.50% | 6.22% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
0.56%
Fund Expense Ratio :
0.56%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 09/28/2007 |
|---|
| w/o sales charge | -15.70% | -6.92% | 4.93% | 6.12% | 10.01% | 5.31% |
| Lipper Category Avg. Equity Income Funds | - | - | - | - | - | - |
| Russell 1000® Value Index | -12.86% | -6.82% | 6.87% | 7.17% | 10.50% | 6.22% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
0.56%
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
The Fund changed its investment strategy on 09/28/2007. Performance is calculated from this date.
TEN LARGEST HOLDINGS as of 05/31/2022View Portfolio
| Holding | Assets |
|---|---|
| UnitedHealth Group Inc | 4.3% |
| NextEra Energy Inc | 3.6% |
| Pfizer Inc | 3.4% |
| Morgan Stanley | 3.3% |
| Marathon Petroleum Corp | 3.1% |
| AbbVie Inc | 2.9% |
| Chevron Corp | 2.9% |
| Shell PLC | 2.9% |
| Allstate Corp/The | 2.8% |
| Northrop Grumman Corp | 2.8% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 05/31/2022View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
12-Month Dividend Yield 1 as of 07/01/2022
| w/o sales charge | 2.09% |
30-Day Standardized Yield 2 as of 05/31/2022
| Subsidized3 | Un-Subsidized4 | |
|---|---|---|
| w/o sales charge | 1.62% | 1.62% |
Fund Expense Ratio :
0.56%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 09/28/2007 |
|---|
| w/o sales charge | -15.70% | -6.92% | 4.93% | 6.12% | 10.01% | 5.31% |
| Lipper Category Avg. Equity Income Funds | - | - | - | - | - | - |
| Russell 1000® Value Index | -12.86% | -6.82% | 6.87% | 7.17% | 10.50% | 6.22% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
0.56%
Fund Expense Ratio :
0.56%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 09/28/2007 |
|---|
| w/o sales charge | -15.70% | -6.92% | 4.93% | 6.12% | 10.01% | 5.31% |
| Lipper Category Avg. Equity Income Funds | - | - | - | - | - | - |
| Russell 1000® Value Index | -12.86% | -6.82% | 6.87% | 7.17% | 10.50% | 6.22% |
Performance data for the Lipper Category Average and for the Index is shown as soon as it becomes available.
Fund Expense Ratio :
0.56%
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
The Fund changed its investment strategy on 09/28/2007. Performance is calculated from this date.
| Year | Fund Returns | Russell 1000® Value Index |
|---|
| 2021 | 26.91% | 25.16% |
| 2020 | -1.11% | 2.80% |
| 2019 | 25.50% | 26.54% |
| 2018 | -7.32% | -8.27% |
| 2017 | 16.30% | 13.66% |
| 2016 | 17.52% | 17.34% |
| 2015 | -4.06% | -3.83% |
| 2014 | 12.23% | 13.45% |
| 2013 | 32.45% | 32.53% |
| 2012 | 16.18% | 17.51% |
| 2011 | -7.68% | - |
| 2010 | 14.69% | - |
| 2009 | 19.68% | - |
| 2008 | -37.02% | - |
| 2007 | 3.73% | - |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2022 | -4.36% | -11.86% | - | - | -14.83% |
| 2021 | 8.77% | 5.67% | -0.06% | 10.50% | 26.91% |
| 2020 | -27.93% | 15.62% | 5.36% | 12.64% | -1.11% |
| 2019 | 10.64% | 3.85% | 2.48% | 6.58% | 25.50% |
| 2018 | -2.41% | 0.53% | 6.57% | -11.36% | -7.32% |
| 2017 | 4.14% | 2.10% | 3.03% | 6.16% | 16.30% |
| 2016 | 2.49% | 3.26% | 3.75% | 7.04% | 17.52% |
| 2015 | 0.39% | -1.19% | -7.53% | 4.61% | -4.06% |
| 2014 | 2.32% | 4.02% | -0.07% | 5.52% | 12.23% |
| 2013 | 10.95% | 3.91% | 4.55% | 9.89% | 32.45% |
| 2012 | 12.67% | -4.71% | 6.75% | 1.37% | 16.18% |
| 2011 | 5.64% | -2.71% | -20.68% | 13.24% | -7.68% |
| 2010 | 6.86% | -14.38% | 10.42% | 13.53% | 14.69% |
| 2009 | -16.42% | 18.85% | 16.35% | 3.55% | 19.68% |
| 2008 | -9.66% | -6.09% | -6.58% | -20.54% | -37.02% |
| 2007 | 0.38% | 5.22% | 1.73% | -3.45% | 3.73% |
NAV HISTORICAL PRICES
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| UnitedHealth Group Inc | Health Care | 4.3% |
| NextEra Energy Inc | Utilities | 3.6% |
| Pfizer Inc | Health Care | 3.4% |
| Morgan Stanley | Financials | 3.3% |
| Marathon Petroleum Corp | Energy | 3.1% |
| AbbVie Inc | Health Care | 2.9% |
| Chevron Corp | Energy | 2.9% |
| Shell PLC | Energy | 2.9% |
| Allstate Corp/The | Financials | 2.8% |
| Northrop Grumman Corp | Industrials | 2.8% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| UnitedHealth Group Inc | Health Care | 4.3% |
| NextEra Energy Inc | Utilities | 3.6% |
| Pfizer Inc | Health Care | 3.4% |
| Morgan Stanley | Financials | 3.3% |
| Marathon Petroleum Corp | Energy | 3.1% |
| AbbVie Inc | Health Care | 2.9% |
| Shell PLC | Energy | 2.9% |
| Chevron Corp | Energy | 2.9% |
| Allstate Corp/The | Financials | 2.8% |
| Northrop Grumman Corp | Industrials | 2.8% |
| Ameriprise Financial Inc | Financials | 2.5% |
| Bank of America Corp | Financials | 2.5% |
| Union Pacific Corp | Industrials | 2.3% |
| Raytheon Technologies Corp | Industrials | 2.3% |
| Organon & Co | Health Care | 2.1% |
| Prologis Inc | Real Estate | 1.9% |
| Cheniere Energy Inc | Energy | 1.9% |
| Procter & Gamble Co/The | Consumer Staples | 1.9% |
| American Financial Group Inc/OH | Financials | 1.9% |
| Eli Lilly & Co | Health Care | 1.8% |
| JPMorgan Chase & Co | Financials | 1.8% |
| Coca-Cola Co/The | Consumer Staples | 1.8% |
| Danaher Corp | Health Care | 1.7% |
| Abbott Laboratories | Health Care | 1.6% |
| Cboe Global Markets Inc | Financials | 1.6% |
| Accenture PLC | Information Technology | 1.6% |
| Cisco Systems Inc | Information Technology | 1.5% |
| Norfolk Southern Corp | Industrials | 1.5% |
| Chubb Ltd | Financials | 1.5% |
| Lowe's Cos Inc | Consumer Discretionary | 1.4% |
| KKR & Co Inc | Financials | 1.4% |
| Apple Inc | Information Technology | 1.4% |
| Parker-Hannifin Corp | Industrials | 1.3% |
| Entergy Corp | Utilities | 1.3% |
| Microsoft Corp | Information Technology | 1.3% |
| Honeywell International Inc | Industrials | 1.2% |
| Reliance Steel & Aluminum Co | Materials | 1.2% |
| Alexandria Real Estate Equities Inc | Real Estate | 1.2% |
| Life Storage Inc | Real Estate | 1.2% |
| Hilton Worldwide Holdings Inc | Consumer Discretionary | 1.1% |
| Lam Research Corp | Information Technology | 1.1% |
| Home Depot Inc/The | Consumer Discretionary | 1.0% |
| Nutrien Ltd | Materials | 1.0% |
| Target Corp | Consumer Discretionary | 1.0% |
| Costco Wholesale Corp | Consumer Staples | 0.9% |
| Algonquin Power & Utilities Corp | Utilities | 0.9% |
| Dover Corp | Industrials | 0.9% |
| Nasdaq Inc | Financials | 0.9% |
| Fidelity National Financial Inc | Financials | 0.8% |
| Texas Instruments Inc | Information Technology | 0.8% |
| Walmart Inc | Consumer Staples | 0.8% |
| Samsung Electronics Co Ltd | Information Technology | 0.8% |
| Comcast Corp | Communication Services | 0.7% |
| Agilent Technologies Inc | Health Care | 0.7% |
| Valvoline Inc | Materials | 0.7% |
| Avery Dennison Corp | Materials | 0.7% |
| BlackRock, Inc. | Financials | 0.5% |
| Bayer AG | Health Care | 0.5% |
| LVMH Moet Hennessy Louis Vuitton SE | Consumer Discretionary | 0.5% |
| Signature Bank/New York NY | Financials | 0.5% |
| Williams-Sonoma Inc | Consumer Discretionary | 0.4% |
| S&P500 EMINI FUT | Undefined | 0.0% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 05/31/2022
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
 0.1%
|
|
| Real Estate | 0.0% | |
| Utilities |
2.5%
|
|
| Consumer Discretionary |
0.3%
|
|
| Consumer Staples |
0.7%
|
|
| Energy |
1.0%
|
|
| Financials |
1.6%
|
|
| Health Care |
1.6%
|
|
| Industrials |
1.4%
|
|
| Information Technology |
1.2%
|
|
| Materials | 0.0% |
PORTFOLIO DETAILS as of 05/31/2022
- Total Net Assets
- $5.90 B
- Number of Holdings
- 62
- Weighted Average Market Cap.
- 219.2 B
- P/B Ratio
- 3.3x
- P/E Ratio
- 15.2x
To view definitions for the above Portfolio Details, Click here.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Contributors & Detractors as of 03/31/2022
Contributors
| Holding | Contribution |
|---|---|
| Chevron Corp | 0.8% |
| Marathon Petroleum Corp. | 0.8% |
| AbbVie, Inc. | 0.7% |
| Cheniere Energy Inc | 0.4% |
| Northrop Grumman Corp | 0.3% |
Detractors
| Holding | Contribution |
|---|---|
| Home Depot Inc/The | -0.5% |
| Danaher Corp Del | -0.5% |
| First Citizens BancShares, Inc | -0.4% |
| Lowe's Cos Inc | -0.4% |
| Kkr & Co Inc | -0.3% |
% Contribution reflects the effect of the individual stock's performance on the Fund's overall performance for the period. Individual holdings and their effect on Fund performance may change significantly over time. Investors should consider the overall performance of the Fund before making a decision on whether or not to invest in the Fund.
Attribution Analysis
| Affiliated Fund | Benchmark | Variance | |||||
|---|---|---|---|---|---|---|---|
| Sector | Avg. Weight | Base Return | Avg. Weight | Base Return | Stock Selection | Group Weight | Total |
The total base return displayed for the Fund does not capture daily cash flow and trading activity and therefore is subject to reasonable variance from the Fund's actual return. Please refer to Lord Abbett Affiliated Fund Performance Results for the Fund's longer-term returns. The Fund is actively managed and portfolio characteristics, such as individual holdings and sector weightings, may change significantly over time.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 07/01/2022
- $0.161
- Dividend Frequency
- Quarterly
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 06/28/2022 | 06/29/2022 | 06/29/2022 | $0.09080 | $15.54 |
| 03/29/2022 | 03/30/2022 | 03/30/2022 | $0.07100 | $17.99 |
Upcoming Dividend Payment Dates
This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 09/28/2022 | 09/29/2022 | 09/29/2022 |
| 12/27/2022 | 12/28/2022 | 12/28/2022 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/22/2021 | 11/23/2021 | $0.4534 | - | $0.4534 | $18.37 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Upcoming Capital Gain Distribution
This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date |
|---|---|
| 11/21/2022 | 11/22/2022 |
Fees & Expenses
Fees & Expenses
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
|
0Documents selected
|
Order | ||||
|---|---|---|---|---|---|
| n/a |
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
| n/a |
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
|||||
| n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
|||||
|
Annual Report
Publish Date:11/03/2015
|
|||||
|
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
|
Fact Sheet
Publish Date:11/03/2015
|
|||||
|
Commentary
Publish Date:11/03/2015
|
|||||